TLDR: "Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to obesity." Key findings: After stopping liraglutide, patients regained ~2.2 kg After stopping semaglutide/tirzepatide, patients regained ~9.7 kg Weight regain was proportional to initial weight loss Lifestyle changes alone DID NOT prevent regain Implication: GLP-1 receptor agonists are not a short-term solution
(4) Dou Y, Lee A, Zhu L, Morton J, Ladiges W
The latest science demonstrates that we should be thinking about GLP-1 medication differently, said Dr
Untreated pernicious anaemia also carries a greater risk of developing stomach cancer
The Potential Role of Glutathione in Managing Stretch Marks While glutathione is not a "cure" for stretch marks, it may support the skin in several ways that improve their appearance
When to Seek Medical Advice About Victoza and Stomach Problems Whilst mild digestive symptoms are common when starting Victoza, certain situations require prompt medical attention